comparisonof the survival and efficacy on E14 ventral mesencephalongraft with different treatments, AG in two doses (10 and 50 μg/kg), or ghrelin agonist JMV-2894 on PD rats treated with 6-OHDA7. This evidence concerns the gene GHRL and Parkinson disease.